ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 285,621 | 144,894 | 221,121 | 53,234 | 100,300 |
| Marketable Securities | 9,131 | 6,307 | 0 | N/A | N/A |
| Receivables | 281,082 | 221,726 | 162,079 | 165,438 | 128,526 |
| Inventories | 143,067 | 136,782 | 111,196 | 105,355 | 81,693 |
| Other current assets | 0 | 0 | 8,020 | 8,020 | 0 |
| TOTAL | $753,117 | $528,456 | $519,816 | $344,261 | $321,775 |
| Non-Current Assets | |||||
| PPE Net | 62,476 | 56,863 | 44,593 | 43,246 | 52,671 |
| Intangibles | 542,006 | 601,824 | 237,230 | 279,856 | 322,010 |
| Other Non-Current Assets | 82,778 | 97,326 | 102,783 | 92,724 | 75,142 |
| TOTAL | $687,260 | $756,013 | $384,606 | $415,826 | $449,823 |
| Total Assets | $1,440,377 | $1,284,469 | $904,422 | $760,087 | $771,598 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 17,268 | 9,172 | 850 | 850 | 850 |
| Accounts payable and accrued liabilities | 62,583 | 45,656 | 36,683 | 29,305 | 22,967 |
| Accrued Expenses | 195,855 | 132,074 | 87,514 | 69,284 | 63,720 |
| Other current liabilities | 167 | 29 | 12,266 | 0 | N/A |
| TOTAL | $278,112 | $194,452 | $145,477 | $99,439 | $87,537 |
| Non-Current Liabilities | |||||
| Long Term Debt | 291,840 | 309,108 | 284,819 | 285,669 | 286,520 |
| Other Non-Current Liabilities | 329,701 | 352,379 | 16,527 | 36,439 | 38,801 |
| TOTAL | $621,541 | $661,487 | $301,346 | $322,108 | $325,321 |
| Total Liabilities | $899,653 | $855,939 | $446,823 | $421,547 | $412,858 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,425 | 21,774 | 21,079 | 17,504 | 17,272 |
| Common Shares | 3 | 2 | 2 | 1 | 1 |
| Retained earnings | -23,099 | -100,279 | -80,132 | -97,286 | -47,765 |
| Other shareholders' equity | 784 | 30,154 | 33,626 | 36,924 | 21,660 |
| TOTAL | $540,724 | $428,530 | $457,599 | $338,540 | $358,740 |
| Total Liabilities And Equity | $1,440,377 | $1,284,469 | $904,422 | $760,087 | $771,598 |